Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05872165
Other study ID # University of cairo PHT
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 1, 2023
Est. completion date September 1, 2023

Study information

Verified date May 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparison between 2 groups of chronic lateral epicondylitis, to determine the effect of ozonated media phonophoresis on chronic lateral epicondylitis.


Description:

40 patients (male and female), patients age would be ranged from 30 to 50 years, would be randomly allocated using sealed envelope into randomly two matched group (A and B), Group A (Experimental): 20 patients would receive ultrasonic with ozonated gel as a coupling medium (phonophoresis) (1 MHz, 1 W/cm2continuous mode) for 5 min. plus, conventional physical therapy program consists of (conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints). 3 times per week for 4 weeks. Group B (control):20 patients will receive conventional physical therapy program consists of (conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints) 3times per week for 4 weeks.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date September 1, 2023
Est. primary completion date August 1, 2023
Accepts healthy volunteers No
Gender All
Age group 30 Years to 50 Years
Eligibility Inclusion Criteria: - All patients would be diagnosed as chronic lateral epicondylitis from both genders. - Patients with chronic lateral epicondylitis that diagnosed by orthopedist. - Positive clinical manifestation in all patients. - Pain onset is more than 3 months. - All participants must be medically stable and not be treated with analgesics or any medication which may cause misleading results. - All patients had body mass index between 18.5 and 29.9 kg/m2. Exclusion Criteria: - Subjects would be excluded if they have: Received intra articular injection from duration less than 3 months. - Elbow instability. - History of cancer. - Pregnancy - Infection. - Skin diseases on elbow area. - Open wound in elbow. - Shoulder or elbow fractures - Systemic diseases such as rheumatoid arthritis, Reiter's syndrome, or diabetes. - Neurological diseases. - Severe medical or psychiatric disorders. - Elbow surgery. - Entrapment of the radial nerve. - Arthritis and effusion of the elbow.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
phonophoresis
1 MHz, 1 W/cm2continuous mode of ultrasound therapy for 5 min. using ozonated gel as a coupling medium
Other:
conventional physical therapy
conventional TENS (100 Hz) for 30 min - hot pack for 20 min- stretching and strengthening exercises, wrist rest splints 3times per week for 4 weeks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Pain status assessment of pain using (visual analogue scale)s a horizontal line, 100 mm in length, anchored by word descriptors at each end. 2) The patient mark millimeters ed on the line the point that they feel ed represents their perception of their current state. The VAS score is determined by measuring in from the start point of the line to the point that the patient marks It was used to evaluate pain intensity. The VAS is a self. reported pain meas urement scale. The extremes of the line are labelled as no pain and worst pain. Each subject was asked to mark the point on the line that exactly corresponded to his/her pain . 4 weeks
Primary wrist ROM Measurment of wrist range of motion using universal goniometer 4 weeks
Primary Hand grip strength measurment of hand grip strength using hand grip dynamometer 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05552209 - Assessment of the Safety and Performance of Elbow Supports in the Context of Epicondylitis or a Return to Sport After Sprain
Withdrawn NCT02861183 - Study of Sodium Hyaluronate to Provide Symptomatic Relief of Lateral Epicondylosis (Tennis Elbow) N/A
Completed NCT02378285 - Treatment of Epicondylitis by Ultrasound-guided Local Injections of PRP (Platelet Rich Plasma) N/A
Recruiting NCT05552235 - Assessment of the Safety and Performance of an Elbow Brace in the Prevention of Injuries During Sports Practice N/A
Not yet recruiting NCT05238090 - Efficacy of a Stretching Protocol for Lateral Epicondylitis N/A
Completed NCT03896204 - Effect of Telephone-supported Joint Protection Technique Training N/A
Completed NCT04729400 - Percutaneous Electrolysis and Vacuum Myofascial Therapy deviceTrial. N/A
Completed NCT03225404 - Effectiveness of Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia. A Single-Blind Randomized Controlled Trial. N/A
Not yet recruiting NCT01269879 - VIBration Training in EpicondylitiS Phase 3
Active, not recruiting NCT01185951 - TENDOSHOCK-2010 Combination Therapy for Athletic Tendinopathies Phase 2
Not yet recruiting NCT01273688 - Eccentric Training With or Without Elbow Brace for Epicondylitis Phase 3
Not yet recruiting NCT05853029 - Combined Shockwave Therapy Versus Focused Shockwave Therapy in Patients With Lateral Epicondylitis N/A
Completed NCT01945528 - Platelet Rich Plasma (PRP) in Chronic Epicondylitis Phase 3
Completed NCT03380559 - A Phase III Study to Evaluate Efficacy of Botulinum Toxin for Treating Epicondylitis Phase 3
Completed NCT00382941 - Study of LED Phototherapy for Musculoligamentous Lesions N/A